A meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally resectable esophageal cancer based on RCTs
The results of this study suggest that in the perioperative management of locally resectable esophageal cancer (including gastroesophageal junction cancer), existing data do not yet demonstrate a significant survival advantage for NCRT over NCT. Individualized decision-making is therefore recommended.
Authors
- Tinghui Xu (ORCID: https://orcid.org/0000-0003-0611-5872)
- Xinfeng Yu
- J Fei
- Xiaoming Zhang
- Jiamu Zheng
- Lei Wang
- Shiyan Zhang
Institutions
- Zhejiang Chinese Medical University (CN)
- Integrated Chinese Medicine (China) (HK)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.3389/fonc.2026.1728150
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00